2024 HCPCS Code C8927
Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for monitoring purposes, including probe placement, real time 2-dimensional image acquisition and interpretation leading to ongoing (continuous) assessment of (dynamically changing) cardiac pumping function and to therapeutic measures on an immediate time basis
TAGS: acquisition contrast transesophageal interpretation assessment pumping basis measures immediate probe ongoing cardiac echocardiography monitoring leading function therapeutic followed
Short Description | Tee w or w/o fol w/cont, mon |
HCPCS Coverage Code | D - Special coverage instructions apply |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Action Effective Date | January 01, 2008 |
HCPCS Code Added Date | January 01, 2008 |
HCPCS Pricing Indicator Code | 53 - Statute |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Coverage Issues Manual Reference Section Number | |
HCPCS Type Of Service Code | 4 - Diagnostic radiology |
HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- C9138 - Nuwiq factor viii recomb
- C9139 - Idelvion, 1 i.u.
- C9140 - Afstyla factor viii recomb
- C9141 - Factor viii pegylated-aucl
- C9142 - Inj, alymsys, 10 mg
- C9143 - Cocaine hcl nasal (numbrino)
- C9144 - Inj, bupivacaine (posimir)
- C9145 - Inj, aponvie, 1 mg
- C9146 - Inj, elahere, 1 mg
- C9147 - Inj, tremelimumab-actl, 1 mg
- C9148 - Inj, teclistamab-cqyv, 0.5mg
- C9149 - Inj, teplizumab-mzwv, 5 mcg
- C9150 - Xe129 xenon, diagnostic
- C9151 - Inj, pegcetacoplan 1 mg
- C9152 - Inj, abilify asimtufii, 1 mg
- C9153 - Inj, amisulpride, 1 mg
- C9154 - Inj buprenorph (brixadi) 1mg
- C9155 - Inj epcoritamab-bysp,0.16 mg
- C9156 - Flotufolastat f18, dia 1 mci
- C9157 - Inj, tofersen, 1 mg